Innovator’s Pitch Challenge

Vote for Us

Interested in Connecting? Please contact:
John Ramunas
CEO
ramunas@rejuvenationtech.com

Message the company or request a 1:1 meeting here

One dose of Rejuvenation?s patented biologic, telomerase mRNA (TERT mRNA), reverses years of telomere shortening. TERT mRNA is a platform therapeutic: in preclinical models, TERT mRNA lipid nanoparticles reduce lung fibrosis, improve lung function, reduce liver fibrosis and inflammation, and extend survival. Now: Fatal diseases. Future: Everyone.

Pitch Video

Slide Deck